# Edgewise Therapeutics, Inc. (EWTX): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/ewtx for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Edgewise Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing small-molecule treatments for a range of musculoskeletal disorders. Its leading investigational drug, EDG-5506, is an orally administered compound specifically engineered to tackle the fundamental genetic causes of dystrophinopathies, including Duchenne and Becker muscular dystrophy. This candidate has successfully concluded its Phase 1 clinical trial. Beyond EDG-5506, Edgewise maintains a pipeline of precision medicine candidates designed to modulate key muscle proteins, thereby addressing various genetically d...

## Quote & Key Metrics

As of 2026-10-22:

| Metric | Value |
|---|---|
| Price | $39.99 USD |
| Market Cap | $4.30B |
| P/E (TTM) | — |
| EPS (TTM) | −$1.85 |
| 52-Week Range | $14.85 – $48.51 |
| Dividend Yield (TTM) | — |

## Dividend

EWTX has no dividend payment history in our records.

## Frequently Asked Questions

### What does Edgewise Therapeutics, Inc. do?

Edgewise Therapeutics, Inc. (EWTX) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is EWTX's market cap?

Edgewise Therapeutics, Inc. (EWTX) has a market capitalization of approximately $4.30 billion, as of October 22, 2026, based on the most recent share price and shares outstanding.

### Does EWTX pay a dividend?

No, Edgewise Therapeutics, Inc. (EWTX) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is EWTX profitable?

Edgewise Therapeutics, Inc. (EWTX) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has EWTX ever paid a dividend?

No. Dividend Data's records show no dividend payments from Edgewise Therapeutics, Inc. (EWTX). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/ewtx
- Dividend history & safety: https://www.dividenddata.com/stocks/ewtx/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/ewtx/earnings
- Financial statements: https://www.dividenddata.com/stocks/ewtx/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/ewtx/valuation
- Peer comparison: https://www.dividenddata.com/stocks/ewtx/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.